Stephen Berenson is of Seres Therapeutics, Inc.. Currently has a direct ownership of 3,589 shares of MCRB, which is worth approximately $2,763. The most recent transaction as insider was on Nov 23, 2020, when has been sold 3,589 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.59K
0% 3M change
0% 12M change
Total Value Held $2,763

Stephen Berenson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 23 2020
BUY
Other acquisition or disposition
-
3,589 Added 50.0%
3,589 Common Stock

Also insider at

MRNA
Moderna, Inc. Healthcare
SB

Stephen Berenson

Cambridge, MA

Track Institutional and Insider Activities on MCRB

Follow Seres Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MCRB shares.

Notify only if

Insider Trading

Get notified when an Seres Therapeutics, Inc. insider buys or sells MCRB shares.

Notify only if

News

Receive news related to Seres Therapeutics, Inc.

Track Activities on MCRB